Tatu Rojalin

Tatu Rojalin

Auto-generated profile, based on publicly available information

Tatu Rojalin

Division of Pharmaceutical Biosciences Centre for Drug Research University of Helsinki Helsinki 00014 Finland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2017 in Advanced Biosystems
Verified
Journal Article
Closed access
PDF file
RCRandy Carney
Randy Carney
SHSidhartha Hazari
Sidhartha Hazari
TRTatu Rojalin
Tatu Rojalin
AKAlisha Knudson
Alisha Knudson
TGTingjuan Gao
Tingjuan Gao
KLKit S. Lam
Kit S. Lam

4 August 2022 in Nano Letters
Verified
Journal Article
Open access
LZLu Zhang
Lu Zhang
RBRuonan Bo
Ruonan Bo
YWYi Wu
Yi Wu
LLLongmeng Li
Longmeng Li
ZZZheng Zhu
Zheng Zhu
KLKit S. Lam
Kit S. Lam
Immune checkpoint blockade (ICB) therapy has revolutionized clinical oncology. However, the efficacy of ICB therapy is limited by the ineffective infiltration of T effector (Teff) cells to tumors and the immunosuppressive tumor microenvironment (TME). Here, we report a programmable tumor cells/Teff cells bispecific nano-immunoengager (NIE) that can circumvent these limitations to improve ICB therapy. The peptidic nanoparticles (NIE-NPs) bind tumor cell surface α3β1 integrin and undergo in situ transformation into nanofibrillar network nanofibers (NIE-NFs). The prolonged retained nanofibrillar network at the TME captures Teff cells via the activatable α4β1 integrin ligand and allows sustained release of resiquimod for immunomodulation. This bispecific NIE eliminates syngeneic 4T1 breast cancer and Lewis lung cancer models in mice, when given together with anti-PD-1 antibody. The in vivo structural transformation-based supramolecular bispecific NIE represents an innovative class of programmable receptor-mediated targeted immunotherapeutics to greatly enhance ICB therapy against cancers.

8 August 2023 in Chemical & Biomedical Imaging
Verified
Journal Article
Open access
NPNoah Pacifici
Noah Pacifici
TRTatu Rojalin
Tatu Rojalin
RCRandy Carney
Randy Carney
JLJamal S. Lewis
Jamal S. Lewis
Vomocytosis is a process by which fungal pathogens, for instance, Cryptococcus neoformans (CN), escape from the digestive phagolysosome of phagocytic cells after ingestion. Interestingly, this expulsion leaves both the pathogen and phagocyte unharmed, and is believed to be an important mechanism by which CNs disseminate throughout infected hosts. This phenomenon was discovered in 2006, and research to date has relied almost entirely on quantification via manual counting of vomocytosis events in time-lapse microscopy videos. This archaic method has the significant disadvantages of requiring excessive labor in manual analysis, limited throughput capabilities, and low accuracy due to subjectivity. Here, we present an alternative method to measure vomocytosis rates using a multi-fluorophore reporter system comprised of two in situ staining steps during infection and a flow cytometry readout. This approach overcomes the limitations of conventional time lapse microscopy methods, with key advantages of high throughput capability, simple procedural steps, and accurate objective readouts. This study rigorously characterizes this vomocytosis reporter system in CN-infected MΦ and DC cultures via fluorescence microscopy, confocal microscopy, and flow cytometry. Here, this fluorescent tool is used to observe differences in expulsion rates after phagosome-modifying drug treatments and additionally utilized to distinguish differences in biochemical compositions among fluorescence-activated cell sorted fungal populations via Raman spectroscopy. Furthermore, this reporter scheme is demonstrated to be adaptable for use in measuring potential biomaterial particle expulsion events. Ultimately, the fluorescent reporter system presented here provides a universal tool for vomocytosis rate measurement of phagocytosed material. This facile approach opens the door to previously unfeasible types of vomocytosis-related studies such as high throughput treatment mechanistic screening and downstream characterization of expelled material.

23 May 2017 in Advanced Biosystems
Verified
Journal Article
Closed access
PDF file
RCRandy Carney
Randy Carney
SHSidhartha Hazari
Sidhartha Hazari
TRTatu Rojalin
Tatu Rojalin
AKAlisha Knudson
Alisha Knudson
TGTingjuan Gao
Tingjuan Gao
KLKit S. Lam
Kit S. Lam

22 October 2026 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
TRTatu Rojalin
Tatu Rojalin
AKAleksi Kröger
Aleksi Kröger
EKElle Koivunotko
Elle Koivunotko
BPBenjamin Pörhö
Benjamin Pörhö
TLTimo J Laaksonen
Timo J Laaksonen
MYMarjo Yliperttula
Marjo Yliperttula
Chronic wounds, particularly diabetic foot ulcers, heal unpredictably and impose substantial healthcare costs. Deep learning (DL) systems that integrate complementary data streams could support preclinical studies by assessing wound status and therapy efficacy reliably in small-n studies. We developed a three-branch neural network combining convolutional feature extraction for red-green-blue (RGB) images, infrared thermography, and wound-area measurements to classify healing stage and infer treatment response in diabetic mouse wound model. In descriptive ablation analysis, the model integrating RGB and wound-size inputs achieved higher accuracy than the RGB-only configuration (0.75 vs. 0.70), suggesting that explicit size context provided useful complementary information. Thermal images appeared qualitatively informative during early healing but contributed limited additional signal later, likely reflecting subtle inflammatory gradients or angiogenesis in healthy murine skin; this observation motivated a constrained weighted-fusion strategy. In the development-stage comparison, static fusion with tunable fixed weights yielded the highest observed performance (∼0.85 accuracy on the development test subject). Grad-CAM visualizations showed that predictions arose from biologically relevant regions rather than image artifacts. Experiments without subject-level partitioning produced inflated metrics, underscoring the need for grouping by subject to ensure generalizable evaluation. Nested Leave-One-Group-Out cross-validation with KerasTuner-based hyperparameter tuning yielded a mean accuracy of 0.71, estimating performance on unseen subjects. This resulting proof-of-concept model predicts treatment responses for wounds treated with nanofibrillated-cellulose hydrogel. Multimodal DL combining standard and thermal photography with size metrics can stage wound healing and detect divergent treatment trajectories and thus be used in preclinical efficacy evaluation of novel wound treatments. With larger, clinically annotated datasets, this approach could be applied in a clinical setting as well.

27 January 2026 in Environmental Pollution
Verified
Journal Article
Open access
HOHannah J. O'TOole
Hannah J. O'TOole
AJAnchaleena James
Anchaleena James
NNNathifa Nasim
Nathifa Nasim
DHDustin J. Hadley
Dustin J. Hadley
EHElizabeth J. Hale
Elizabeth J. Hale
RCRandy Carney
Randy Carney
Chronic exposure to traffic-related air pollution (TRAP) is linked to increased risk of neurodegenerative diseases, including Alzheimer disease (AD). Ultrafine particulate matter (UFPM) is a suspected driver of TRAP neurotoxicity, but its spatial interactions with AD pathology remain poorly defined. We investigated the distribution, composition, and pathological context of TRAP-derived UFPM in the hippocampus of TgF344-AD rats chronically exposed to TRAP or filtered air (FA) for 14 months. Using a multimodal imaging workflow that combines enhanced darkfield hyperspectral imaging (EDF-HSI) with confocal immunofluorescence for microglia (CD68/Iba1) and amyloid beta (Aβ) plaques (Thioflavin S), we mapped the localization and spectral properties of UFPM in situ. UFPM accumulation was elevated in TRAP-exposed females, suggesting sex-specific vulnerability in blood-brain barrier permeability or particle accumulation. Particles near plaques showed red-shifted spectral signatures, suggestive of biochemical transformation. Dimension reduction revealed clustering of particle spectra by TRAP exposure and plaque proximity. However, UFPM was rarely found within plaques or microglia, implying indirect neuroimmune modulation. These findings highlight a novel spatial and spectral imaging approach for characterizing environmental nanoparticle interactions in the brain and suggests chronic TRAP exposure may influence AD-related inflammation and pathology in a sex- and region-dependent manner in this rodent model.